Vemedia, a consumer healthcare company that markets leading self-medication brands in selected western European countries and Hong Kong, has been sold by its shareholders to Charterhouse Capital Partners at a value of EUR 375 million. Eubelius assisted Damier Group, a 25% shareholder in Vemedia controlled by Yvan Vindevogel, in connection with the sale as well as the subsequent reinvestment of part of the sales proceeds in the acquisition vehicle.
The Eubelius team for this transaction was led by Erwin Destuyver.